ZA915056B - Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages - Google Patents

Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages

Info

Publication number
ZA915056B
ZA915056B ZA915056A ZA915056A ZA915056B ZA 915056 B ZA915056 B ZA 915056B ZA 915056 A ZA915056 A ZA 915056A ZA 915056 A ZA915056 A ZA 915056A ZA 915056 B ZA915056 B ZA 915056B
Authority
ZA
South Africa
Prior art keywords
terminal
internucleotide linkages
oligonucleotide analogs
linkages
nuclease
Prior art date
Application number
ZA915056A
Other languages
English (en)
Inventor
Hannelore Roesch
Roesch Hannelore
Matthias Montenarh
Montenarh Matthias
Anja Froehlich
Froehlich Anja
Hartmut Seliger
Seliger Hartmut
Jose Flavio Ramalho-Ortigao
Flavio Ramalho-Ortigao Jose
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ZA915056B publication Critical patent/ZA915056B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R15/00—Details of measuring arrangements of the types provided for in groups G01R17/00 - G01R29/00, G01R33/00 - G01R33/26 or G01R35/00
    • G01R15/14—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks
    • G01R15/18—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers
    • G01R15/186—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers using current transformers with a core consisting of two or more parts, e.g. clamp-on type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Power Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
ZA915056A 1990-07-02 1991-07-01 Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages ZA915056B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4021019 1990-07-02

Publications (1)

Publication Number Publication Date
ZA915056B true ZA915056B (en) 1992-03-25

Family

ID=6409497

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA915056A ZA915056B (en) 1990-07-02 1991-07-01 Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages

Country Status (22)

Country Link
US (1) US5750669A (fr)
EP (1) EP0464638B1 (fr)
JP (1) JP3186795B2 (fr)
KR (1) KR100200400B1 (fr)
AT (1) ATE151076T1 (fr)
AU (1) AU647143B2 (fr)
CA (1) CA2045891C (fr)
CZ (1) CZ285408B6 (fr)
DE (1) DE59108644D1 (fr)
DK (1) DK0464638T3 (fr)
ES (1) ES2099718T3 (fr)
FI (1) FI104177B (fr)
GR (1) GR3023432T3 (fr)
HU (1) HU215147B (fr)
IE (1) IE912309A1 (fr)
IL (1) IL98672A (fr)
NO (1) NO303018B1 (fr)
NZ (1) NZ238769A (fr)
PT (1) PT98169B (fr)
SK (1) SK279544B6 (fr)
TW (1) TW206232B (fr)
ZA (1) ZA915056B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223618A (en) * 1990-08-13 1993-06-29 Isis Pharmaceuticals, Inc. 4'-desmethyl nucleoside analog compounds
DE59306170D1 (de) * 1992-09-24 1997-05-22 Hoechst Ag Oligoribonucleotid- und Ribozym-Analoga mit terminalen 3'-3'-bzw.5'-5'-Verknüpfungen
CA2159629A1 (fr) * 1993-03-31 1994-10-13 Sanofi Oligonucleotides avec des liens amide a la place des liens phosphodiester
US6015886A (en) * 1993-05-24 2000-01-18 Chemgenes Corporation Oligonucleotide phosphate esters
US6605708B1 (en) * 1993-07-28 2003-08-12 Hybridon, Inc. Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7309692B1 (en) 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′－单磷酸化寡核苷酸
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
US6087112A (en) 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US6271360B1 (en) * 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
EP1702983A3 (fr) 2000-04-13 2007-01-10 Medical University of South Carolina Agents toxiques, ribozymes, ADNzymes et oligonucléotides antisens spécifiques des tissus et des pathogènes et procédé d'utilisation associé
AU2001272714A1 (en) * 2000-06-13 2001-12-24 Proligo Llc Universal solid supports for solid phase oligosynthesis and methods for their preparation and use
ES2298269T3 (es) * 2000-09-26 2008-05-16 Idera Pharmaceuticals, Inc. Modulacion de la actividad inmunoestimulante de analogos oligonucleotidicos inmunoestimulantes mediante cambios quimicos posicionales.
GB0114007D0 (en) * 2001-06-08 2001-08-01 Isis Innovation Oilgonucleotides
US7070933B2 (en) * 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
WO2003061386A1 (fr) * 2002-01-03 2003-07-31 Board Of Regents, The University Of Texas System Oligonucleotides antisens wt1 inhibant le cancer du sein
JP2005526497A (ja) * 2002-02-04 2005-09-08 ビオミラ，インコーポレーテッド 免疫刺激性、共有結合性脂質化オリゴヌクレオチド
WO2004044132A2 (fr) 2002-11-05 2004-05-27 Isis Pharmaceuticals, Inc. Oligonucleotides modifies a utiliser dans l'interference de l'arn
WO2004044138A2 (fr) 2002-11-05 2004-05-27 Isis Pharmaceuticals, Inc. Composes oligomere chimeres et leur utilisation dans la modulation genique
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
JP2008501693A (ja) * 2004-06-03 2008-01-24 アイシス ファーマシューティカルズ、インク． 遺伝子調節で使用するための個別に調節された鎖を有する二本鎖組成物
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
CA2679750A1 (fr) 2008-09-23 2010-03-23 Nexus Dx, Inc. Methodes de detection d'acides nucleiques dans un echantillon
EP2781523A1 (fr) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Analogues oligonucléotides lipophiles
KR101323476B1 (ko) * 2013-06-12 2013-10-31 조선미 건물용 층간소음 방지재와 이를 이용한 층간소음 방지구조 및 그 시공 방법
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
AU2017248189B2 (en) * 2016-04-08 2021-04-29 Translate Bio, Inc. Multimeric coding nucleic acid and uses thereof
WO2018223056A1 (fr) 2017-06-02 2018-12-06 Wave Life Sciences Ltd. Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3775264A4 (fr) 2018-04-05 2022-03-23 Tsinghua University Procédés de séquençage et de production de séquences d'acides nucléiques
AU2019252680A1 (en) * 2018-04-12 2020-10-22 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123610A (en) * 1977-03-09 1978-10-31 The United States Government Nucleic acid crosslinking agent and affinity inactivation of nucleic acids therewith
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
US4795700A (en) * 1985-01-25 1989-01-03 California Institute Of Technology Nucleic acid probes and methods of using same
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
EP0406309A4 (en) * 1988-03-25 1992-08-19 The University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
AU5418290A (en) * 1989-03-31 1990-11-05 University Patents Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections

Also Published As

Publication number Publication date
IE912309A1 (en) 1992-01-15
FI104177B1 (fi) 1999-11-30
DE59108644D1 (de) 1997-05-07
HU912215D0 (en) 1991-12-30
FI913169A0 (fi) 1991-06-28
HUT62010A (en) 1993-03-29
US5750669A (en) 1998-05-12
PT98169A (pt) 1993-09-30
PT98169B (pt) 1998-12-31
JPH05222088A (ja) 1993-08-31
EP0464638A3 (en) 1992-09-02
NO303018B1 (no) 1998-05-18
FI913169A (fi) 1992-01-03
JP3186795B2 (ja) 2001-07-11
GR3023432T3 (en) 1997-08-29
NZ238769A (en) 1993-11-25
AU647143B2 (en) 1994-03-17
NO912585D0 (no) 1991-07-01
KR100200400B1 (ko) 1999-06-15
CZ285408B6 (cs) 1999-08-11
CA2045891C (fr) 2003-07-22
KR920002625A (ko) 1992-02-28
CS201491A3 (en) 1992-01-15
FI104177B (fi) 1999-11-30
IL98672A (en) 1995-12-08
HU215147B (hu) 2000-03-28
DK0464638T3 (da) 1997-10-13
SK279544B6 (sk) 1998-12-02
EP0464638A2 (fr) 1992-01-08
AU7947591A (en) 1992-01-02
NO912585L (no) 1992-01-03
IL98672A0 (en) 1992-07-15
EP0464638B1 (fr) 1997-04-02
ES2099718T3 (es) 1997-06-01
CA2045891A1 (fr) 1992-01-03
TW206232B (fr) 1993-05-21
ATE151076T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
ZA915056B (en) Oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages
WO1991006626A3 (fr) Formation d'une triple chaine helicoidale en therapie oligonucleotidique
NO171981C (no) Alkynylaminonukleotider, fremgangsmaate for fremstilling derav, 7-jodnukleotider, merkede alkynyl-aminonukleotider samt fremgangsmaate for fremstilling av 7-(3-amino-1-propynyl)-2',3'-dideoxyguanosin-5'-trifosfat
EP0651759A4 (fr) Nouveaux 2'-o-alkyle nucleosides et phosporamidites, leurs procedes de preparation et d'utilisation.
DE3853060D1 (de) Verfahren zur Herstellung von Oligonucleotiden.
MA22905A1 (fr) Nouvelles sequences d'adn .
ZA8845B (en) T7 dna polymerase
FR2569421B1 (fr) Plasmide et fragment d'adn comprenant un gene pour la resistance a la tetracycline, culture de microorganisme contenant le plasmide precite et microorganisme contenant ledit fragment d'adn
DE3889393D1 (de) Verfahren zur Herstellung von 2,2,6,6-Tetramethyl-4-piperidylaminen.
AU5720498A (en) Chemical synthesis of nucleosides analogs and their incorporation into polynucleotides
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
WO1994005791A3 (fr) Facteur influant sur la croissance du tissu dorsal et compositions
IL75963A0 (en) Interferon derivatives,their preparation and pharmaceutical compositions containing them
FR2591596B1 (fr) Nouvelles 4h-triazolo(4,3-a)(1,4)benzodiazepines, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
GR3004988T3 (fr)
LTIP1519A (en) Solution, set, process for elongation of the oligonucleotidic primer, process of dna amplification
GB2197651B (en) Rna polymerase gene microorganism having said gene and the production of rna polymerase by the use of said microorganism
FR2674253B1 (fr) Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
AU629423B2 (en) Treatment of multi-drug resistant tumors with quinolyloxazole-2-ones
WO1993013204A3 (fr) Stimulant de la division de cellules animales
Johnstone Geology of the Stoughton-Roquemaure group, Beatty and Munro townships, northeastern Ontario.
Gharavi Molecular cloning of the human lipoxygenase gene
Lam The ribosomal RNA genes of Halobacterium cutirubrum
DE69011293D1 (de) Verfahren zur Herstellung von 4,4'-Dihydroxybiphenyl.
CA2143442A1 (fr) Facteur et compositions affectant le tissu dorsal